{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T16:42:08Z","timestamp":1782924128060,"version":"3.54.5"},"reference-count":220,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing Municipality","doi-asserted-by":"publisher","award":["CSTB2022NSCQ-MSX0530"],"award-info":[{"award-number":["CSTB2022NSCQ-MSX0530"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing Municipality","doi-asserted-by":"publisher","award":["cstc2022ycjh-bgzxm0016"],"award-info":[{"award-number":["cstc2022ycjh-bgzxm0016"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012669","name":"Natural Science Foundation Project of Chongqing","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012669","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82300201"],"award-info":[{"award-number":["82300201"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.cellsig.2025.112317","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T03:00:19Z","timestamp":1765422019000},"page":"112317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Mechanistic insights into L-asparaginase resistance in cancers"],"prefix":"10.1016","volume":"139","author":[{"given":"Longfei","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjuan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.cellsig.2025.112317_bb0005","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1038\/sj.leu.2401980","article-title":"Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995)","volume":"14","author":"Silverman","year":"2000","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.cellsig.2025.112317_bb0010","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1182\/blood.V97.5.1211","article-title":"Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01","volume":"97","author":"Silverman","year":"2001","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.cellsig.2025.112317_bb0015","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1182\/blood-2004-04-1616","article-title":"Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children\u2019s Research Hospital","volume":"104","author":"Pui","year":"2004","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.cellsig.2025.112317_bb0020","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1182\/blood-2007-09-112920","article-title":"Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95","volume":"111","author":"M\u00f6ricke","year":"2008","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.cellsig.2025.112317_bb0025","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/s42255-025-01245-6","article-title":"Asparagine deprivation enhances T cell antitumour response in patients via ROS-mediated metabolic and signal adaptations","volume":"7","author":"Chang","year":"2025","journal-title":"Nat. Metab."},{"issue":"6","key":"10.1016\/j.cellsig.2025.112317_bb0030","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1084\/jem.98.6.565","article-title":"Regression of transplanted lymphomas induced in vivo by means of normal guinea pig serum. I. Course of transplanted cancers of various kinds in mice and rats given guinea pig serum, horse serum, or rabbit serum","volume":"98","author":"Kidd","year":"1953","journal-title":"J. Exp. Med."},{"issue":"4793","key":"10.1016\/j.cellsig.2025.112317_bb0035","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/1911114a0","article-title":"Evidence that the L-Asparaginase Activity of Guinea Pig Serum is responsible for its Antilymphoma Effects","volume":"191","author":"Broome","year":"1961","journal-title":"Nature"},{"issue":"3713","key":"10.1016\/j.cellsig.2025.112317_bb0040","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1126\/science.151.3713.998","article-title":"Antagonism of purified asparaginase from guinea pig serum toward lymphoma","volume":"151","author":"Yellin","year":"1966","journal-title":"Science"},{"key":"10.1016\/j.cellsig.2025.112317_bb0045","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0003-9861(64)90032-3","article-title":"Tumor inhibitory effect of L-asparaginase from escherichia coli","volume":"105","author":"Mashburn","year":"1964","journal-title":"Arch. Biochem. Biophys."},{"issue":"10","key":"10.1016\/j.cellsig.2025.112317_bb0050","first-page":"2213","article-title":"The antitumor activity of Escherichia coli L-asparaginase","volume":"26","author":"Roberts","year":"1966","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.cellsig.2025.112317_bb0055","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1001\/jama.1967.03130220070012","article-title":"L-asparaginase therapy for leukemia and other malignant neoplasms. Remission in human leukemia","volume":"202","author":"Hill","year":"1967","journal-title":"Jama"},{"issue":"8","key":"10.1016\/j.cellsig.2025.112317_bb0060","first-page":"1574","article-title":"Response to highly purified L-asparaginase during therapy of acute leukemia","volume":"29","author":"Hill","year":"1969","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.cellsig.2025.112317_bb0065","doi-asserted-by":"crossref","first-page":"893","DOI":"10.7326\/0003-4819-74-6-893","article-title":"L-asparaginase: clinical, biochemical, pharmacological, and immunological studies","volume":"74","author":"Capizzi","year":"1971","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.cellsig.2025.112317_bb0070","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/nyas.12496","article-title":"Development of asparaginase Erwinia chrysanthemi for the treatment of acute lymphoblastic leukemia","volume":"1329","author":"Salzer","year":"2014","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.cellsig.2025.112317_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111616","article-title":"Circumventing the side effects of L-asparaginase","volume":"139","author":"Fonseca","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"7571","key":"10.1016\/j.cellsig.2025.112317_bb0080","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0140-6736(68)90977-X","article-title":"A new L-asparaginase with antitumour activity?","volume":"2","author":"Wade","year":"1968","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.cellsig.2025.112317_bb0085","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s40259-013-0051-4","article-title":"Asparaginase Erwinia chrysanthemi (Erwinaze\u00ae): a guide to its use in acute lymphoblastic leukemia in the USA","volume":"27","author":"Keating","year":"2013","journal-title":"BioDrugs"},{"issue":"2","key":"10.1016\/j.cellsig.2025.112317_bb0090","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/1097-0142(197002)25:2<279::AID-CNCR2820250205>3.0.CO;2-7","article-title":"Clinical results of treatment with E. coli L-asparaginase in adults with leukemia, lymphoma, and solid tumors","volume":"25","author":"Clarkson","year":"1970","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.cellsig.2025.112317_bb0095","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/1097-0142(197002)25:2<306::AID-CNCR2820250206>3.0.CO;2-H","article-title":"E. coli L-asparaginase in the treatment of leukemia and solid tumors in 131 children","volume":"25","author":"Tallal","year":"1970","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112317_bb0100","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s002800000207","article-title":"A phase I and pharmacodynamic evaluation of polyethylene glycol-conjugated L-asparaginase in patients with advanced solid tumors","volume":"47","author":"Taylor","year":"2001","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.cellsig.2025.112317_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2015.01.002","article-title":"Recent developments in L-asparaginase discovery and its potential as anticancer agent","volume":"100","author":"Shrivastava","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"5","key":"10.1016\/j.cellsig.2025.112317_bb0110","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1007\/s12010-015-1917-3","article-title":"A Comprehensive Review on L-Asparaginase and Its Applications","volume":"178","author":"Batool","year":"2016","journal-title":"Appl. Biochem. Biotechnol."},{"issue":"2","key":"10.1016\/j.cellsig.2025.112317_bb0115","doi-asserted-by":"crossref","first-page":"104","DOI":"10.18097\/pbmc20226802104","article-title":"Mechanisms of development of side effects and drug resistance to asparaginase and ways to overcome them","volume":"68","author":"Alexandrova","year":"2022","journal-title":"Biomed Khim"},{"issue":"7","key":"10.1016\/j.cellsig.2025.112317_bb0120","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1182\/blood.V90.7.2723","article-title":"In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia","volume":"90","author":"Kaspers","year":"1997","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.cellsig.2025.112317_bb0125","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1038\/leu.2008.165","article-title":"Pharmacokinetic, pharmacodynamic and intracellular effects of PEG-asparaginase in newly diagnosed childhood acute lymphoblastic leukemia: results from a single agent window study","volume":"22","author":"Appel","year":"2008","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.cellsig.2025.112317_bb0130","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.3109\/10428194.2012.658570","article-title":"Clinical impact of in vitro cellular drug resistance on childhood acute lymphoblastic leukemia in Taiwan","volume":"53","author":"Chen","year":"2012","journal-title":"Leuk. Lymphoma"},{"issue":"4","key":"10.1016\/j.cellsig.2025.112317_bb0135","first-page":"268","article-title":"Biological characteristics and prognostic value of in vitro three-drug resistance to prednisolone, L-asparaginase, and vincristine in childhood acute lymphoblastic leukemia","volume":"70","author":"Hongo","year":"1999","journal-title":"Int. J. Hematol."},{"issue":"17","key":"10.1016\/j.cellsig.2025.112317_bb0140","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1200\/JCO.2003.11.031","article-title":"Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia","volume":"21","author":"Den Boer","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cellsig.2025.112317_bb0145","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1146\/annurev.biochem.75.103004.142520","article-title":"Asparagine synthetase chemotherapy","volume":"75","author":"Richards","year":"2006","journal-title":"Annu. Rev. Biochem."},{"issue":"3760","key":"10.1016\/j.cellsig.2025.112317_bb0150","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1126\/science.155.3760.329","article-title":"L-asparaginase: toxicity to normal and leukemic human lymphocytes","volume":"155","author":"Schrek","year":"1967","journal-title":"Science"},{"issue":"3827","key":"10.1016\/j.cellsig.2025.112317_bb0155","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1126\/science.160.3827.533","article-title":"Asparagine synthetase activity of mouse leukemias","volume":"160","author":"Horowitz","year":"1968","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.cellsig.2025.112317_bb0160","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/BF01574256","article-title":"Assignment of structural gene for asparagine synthetase to human chromosome 7","volume":"9","author":"Arfin","year":"1983","journal-title":"Somatic Cell Genet."},{"issue":"3","key":"10.1016\/j.cellsig.2025.112317_bb0165","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0888-7543(89)90329-7","article-title":"Molecular structure of the human asparagine synthetase gene","volume":"4","author":"Zhang","year":"1989","journal-title":"Genomics"},{"issue":"49","key":"10.1016\/j.cellsig.2025.112317_bb0170","doi-asserted-by":"crossref","first-page":"19952","DOI":"10.1074\/jbc.R117.819060","article-title":"Asparagine synthetase: function, structure, and role in disease","volume":"292","author":"Lomelino","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.cellsig.2025.112317_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14040902","article-title":"Novel insights on the use of L-asparaginase as an efficient and safe anti-cancer therapy","volume":"14","author":"Van Trimpont","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.cellsig.2025.112317_bb0180","first-page":"294","article-title":"Biochemical characterization of U937 cells resistant to L-asparaginase: the role of asparagine synthetase","volume":"3","author":"Kiriyama","year":"1989","journal-title":"Leukemia"},{"issue":"16","key":"10.1016\/j.cellsig.2025.112317_bb0185","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJMoa040465","article-title":"Prognostically useful gene-expression profiles in acute myeloid leukemia","volume":"350","author":"Valk","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.cellsig.2025.112317_bb0190","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/pbc.21213","article-title":"Correlation between asparaginase sensitivity and asparagine synthetase protein content, but not mRNA, in acute lymphoblastic leukemia cell lines","volume":"50","author":"Su","year":"2008","journal-title":"Pediatr. Blood Cancer"},{"issue":"6","key":"10.1016\/j.cellsig.2025.112317_bb0195","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJMoa033513","article-title":"Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment","volume":"351","author":"Holleman","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112317_bb0200","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1365-2141.2007.06763.x","article-title":"Genetic alterations determine chemotherapy resistance in childhood T-ALL: modelling in stage-specific cell lines and correlation with diagnostic patient samples","volume":"139","author":"Estes","year":"2007","journal-title":"Br. J. Haematol."},{"issue":"11","key":"10.1016\/j.cellsig.2025.112317_bb0205","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1158\/1535-7163.MCT-06-0447","article-title":"Asparagine synthetase as a causal, predictive biomarker for L-asparaginase activity in ovarian cancer cells","volume":"5","author":"Lorenzi","year":"2006","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112317_bb0210","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jprot.2007.11.009","article-title":"Mass spectrometric quantification of asparagine synthetase in circulating leukemia cells from acute lymphoblastic leukemia patients","volume":"71","author":"Abbatiello","year":"2008","journal-title":"J. Proteome"},{"issue":"5","key":"10.1016\/j.cellsig.2025.112317_bb0215","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.pedneo.2014.10.006","article-title":"Asparaginase Therapy in Pediatric Acute Lymphoblastic Leukemia: A Focus on the Mode of Drug Resistance","volume":"56","author":"Chen","year":"2015","journal-title":"Pediatr. Neonatol."},{"issue":"2","key":"10.1016\/j.cellsig.2025.112317_bb0220","doi-asserted-by":"crossref","DOI":"10.1093\/carcin\/bgaf035","article-title":"GPS2 confers l-asparaginase resistance in acute lymphoblastic leukemia cells through ATF4\/ASNS axis","volume":"46","author":"Chen","year":"2025","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.cellsig.2025.112317_bb0225","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.09436","article-title":"Functional genomic screening reveals asparagine dependence as a metabolic vulnerability in sarcoma","volume":"4","author":"Hettmer","year":"2015","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112317_bb0230","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/bjc.2013.293","article-title":"Asparagine synthetase is an independent predictor of surgical survival and a potential therapeutic target in hepatocellular carcinoma","volume":"109","author":"Zhang","year":"2013","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112317_bb0235","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1021\/acsptsci.0c00196","article-title":"Therapeutic Assessment of Targeting ASNS Combined with l-Asparaginase Treatment in Solid Tumors and Investigation of Resistance Mechanisms","volume":"4","author":"Apfel","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"5","key":"10.1016\/j.cellsig.2025.112317_bb0240","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1158\/1541-7786.MCR-13-0576","article-title":"Asparagine depletion potentiates the cytotoxic effect of chemotherapy against brain tumors","volume":"12","author":"Panosyan","year":"2014","journal-title":"Mol. Cancer Res."},{"issue":"25","key":"10.1016\/j.cellsig.2025.112317_bb0245","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1038\/sj.onc.1207553","article-title":"Tumor-derived p53 mutants induce oncogenesis by transactivating growth-promoting genes","volume":"23","author":"Scian","year":"2004","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112317_bb0250","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1038\/s41467-020-15573-6","article-title":"p53-mediated control of aspartate-asparagine homeostasis dictates LKB1 activity and modulates cell survival","volume":"11","author":"Deng","year":"2020","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.cellsig.2025.112317_bb0255","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.cmet.2020.03.008","article-title":"ZBTB1 regulates asparagine synthesis and leukemia cell response to L-asparaginase","volume":"31","author":"Williams","year":"2020","journal-title":"Cell Metab."},{"issue":"11","key":"10.1016\/j.cellsig.2025.112317_bb0260","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.tig.2021.05.002","article-title":"Navigating the DNA methylation landscape of cancer","volume":"37","author":"Nishiyama","year":"2021","journal-title":"Trends Genet."},{"issue":"7","key":"10.1016\/j.cellsig.2025.112317_bb0265","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/sj.leu.2404216","article-title":"Methylation analysis of asparagine synthetase gene in acute lymphoblastic leukemia cells","volume":"20","author":"Akagi","year":"2006","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.cellsig.2025.112317_bb0270","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1054\/bjoc.2001.2000","article-title":"Hypermethylation of CpG islands in the mouse asparagine synthetase gene: relationship to asparaginase sensitivity in lymphoma cells. Partial methylation in normal cells","volume":"85","author":"Peng","year":"2001","journal-title":"Br. J. Cancer"},{"issue":"22","key":"10.1016\/j.cellsig.2025.112317_bb0275","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1038\/sj.onc.1207498","article-title":"Methylation of the asparagine synthetase promoter in human leukemic cell lines is associated with a specific methyl binding protein","volume":"23","author":"Ren","year":"2004","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112317_bb0280","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1182\/bloodadvances.2021004271","article-title":"Association of allele-specific methylation of the ASNS gene with asparaginase sensitivity and prognosis in T-ALL","volume":"6","author":"Akahane","year":"2022","journal-title":"Blood Adv."},{"issue":"20","key":"10.1016\/j.cellsig.2025.112317_bb0285","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1182\/blood.2019004090","article-title":"Association of aberrant ASNS imprinting with asparaginase sensitivity and chromosomal abnormality in childhood BCP-ALL","volume":"136","author":"Watanabe","year":"2020","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.cellsig.2025.112317_bb0290","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1158\/1078-0432.CCR-18-1844","article-title":"Epigenetic Silencing Affects l-Asparaginase Sensitivity and Predicts Outcome in T-ALL","volume":"25","author":"Touzart","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112317_bb0295","doi-asserted-by":"crossref","DOI":"10.1080\/15592294.2023.2268814","article-title":"Utility of ASNS gene methylation evaluated with the HPLC method as a pharmacogenomic biomarker to predict asparaginase sensitivity in BCP-ALL","volume":"18","author":"Watanabe","year":"2023","journal-title":"Epigenetics"},{"issue":"27","key":"10.1016\/j.cellsig.2025.112317_bb0300","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abn6491","article-title":"Tumoral microenvironment prevents de novo asparagine biosynthesis in B cell lymphoma, regardless of ASNS expression","volume":"8","author":"Grima-Reyes","year":"2022","journal-title":"Sci. Adv."},{"issue":"8","key":"10.1016\/j.cellsig.2025.112317_bb0305","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.exphem.2012.04.005","article-title":"Low expression of asparagine synthetase in lymphoid blasts precludes its role in sensitivity to L-asparaginase","volume":"40","author":"Hermanova","year":"2012","journal-title":"Exp. Hematol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112317_bb0310","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1158\/0008-5472.291.65.1","article-title":"A genome-wide view of the in vitro response to l-asparaginase in acute lymphoblastic leukemia","volume":"65","author":"Fine","year":"2005","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.cellsig.2025.112317_bb0315","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1182\/blood-2002-08-2446","article-title":"Sensitivity to L-asparaginase is not associated with expression levels of asparagine synthetase in t(12;21)+ pediatric ALL","volume":"101","author":"Stams","year":"2003","journal-title":"Blood"},{"issue":"Pt 1","key":"10.1016\/j.cellsig.2025.112317_bb0320","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1042\/bj3580059","article-title":"Multiple adaptive mechanisms affect asparagine synthetase substrate availability in asparaginase-resistant MOLT-4 human leukaemia cells","volume":"358","author":"Aslanian","year":"2001","journal-title":"Biochem. J."},{"issue":"12","key":"10.1016\/j.cellsig.2025.112317_bb0325","article-title":"Human asparagine synthetase associates with the mitotic spindle","volume":"7","author":"Noree","year":"2018","journal-title":"Biol. Open"},{"issue":"12","key":"10.1016\/j.cellsig.2025.112317_bb0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0243742","article-title":"Nuclear targeted Saccharomyces cerevisiae asparagine synthetases associate with the mitotic spindle regardless of their enzymatic activity","volume":"15","author":"Noree","year":"2020","journal-title":"PLoS One"},{"issue":"Pt 1","key":"10.1016\/j.cellsig.2025.112317_bb0335","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1042\/bj3280159","article-title":"Expression, purification, and characterization of recombinant human glutamine synthetase","volume":"328","author":"Listrom","year":"1997","journal-title":"Biochem. J."},{"key":"10.1016\/j.cellsig.2025.112317_bb0340","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.671902","article-title":"Pharmacological vitamin C treatment impedes the growth of endogenous glutamine-dependent cancers by targeting glutamine synthetase","volume":"12","author":"Long","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.cellsig.2025.112317_bb0345","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cmet.2017.12.006","article-title":"As extracellular glutamine levels decline, asparagine becomes an essential amino acid","volume":"27","author":"Pavlova","year":"2018","journal-title":"Cell Metab."},{"issue":"8","key":"10.1016\/j.cellsig.2025.112317_bb0350","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.tibs.2010.05.003","article-title":"Glutamine addiction: a new therapeutic target in cancer","volume":"35","author":"Wise","year":"2010","journal-title":"Trends Biochem. Sci."},{"issue":"49","key":"10.1016\/j.cellsig.2025.112317_bb0355","doi-asserted-by":"crossref","first-page":"19345","DOI":"10.1073\/pnas.0709747104","article-title":"Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis","volume":"104","author":"DeBerardinis","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.cellsig.2025.112317_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2023.113568","article-title":"L-asparaginase anti-tumor activity in pancreatic cancer is dependent on its glutaminase activity and resistance is mediated by glutamine synthetase","volume":"426","author":"Blachier","year":"2023","journal-title":"Exp. Cell Res."},{"issue":"S1","key":"10.1016\/j.cellsig.2025.112317_bb0365","doi-asserted-by":"crossref","DOI":"10.1096\/fasebj.31.1_supplement.809.8","article-title":"Autophagy and glutamine synthetase induction sustain ALL blast resistance to L-asparaginase in human bone marrow mesenchymal stromal cells","volume":"31","author":"Chiu","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.cellsig.2025.112317_bb0370","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.758549","article-title":"Enhanced antitumor effect in liver cancer by amino acid depletion-induced oxidative stress","volume":"11","author":"Okuda","year":"2021","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.cellsig.2025.112317_bb0375","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00280-007-0421-z","article-title":"The inhibition of glutamine synthetase sensitizes human sarcoma cells to L-asparaginase","volume":"60","author":"Tardito","year":"2007","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"6","key":"10.1016\/j.cellsig.2025.112317_bb0380","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000087238","article-title":"Inhibition of glutamine synthetase triggers apoptosis in asparaginase-resistant cells","volume":"15","author":"Rotoli","year":"2005","journal-title":"Cell. Physiol. Biochem."},{"issue":"8","key":"10.1016\/j.cellsig.2025.112317_bb0385","doi-asserted-by":"crossref","first-page":"929","DOI":"10.2174\/156800911797264725","article-title":"L-Asparaginase and inhibitors of glutamine synthetase disclose glutamine addiction of \u03b2-catenin-mutated human hepatocellular carcinoma cells","volume":"11","author":"Tardito","year":"2011","journal-title":"Curr. Cancer Drug Targets"},{"issue":"23","key":"10.1016\/j.cellsig.2025.112317_bb0390","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1182\/blood-2013-10-535112","article-title":"The glutaminase activity of L-asparaginase is not required for anticancer activity against ASNS-negative cells","volume":"123","author":"Chan","year":"2014","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.cellsig.2025.112317_bb0395","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1021\/acs.biochem.4c00763","article-title":"Glutamine synthetase: diverse regulation and functions of an ancient enzyme","volume":"64","author":"Tecson","year":"2025","journal-title":"Biochemistry"},{"issue":"6","key":"10.1016\/j.cellsig.2025.112317_bb0400","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1085\/jgp.8.6.519","article-title":"The metabolism of tumors in the body","volume":"8","author":"Warburg","year":"1927","journal-title":"J. Gen. Physiol."},{"issue":"6487","key":"10.1016\/j.cellsig.2025.112317_bb0405","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw5473","article-title":"Metabolic reprogramming and cancer progression","volume":"368","author":"Faubert","year":"2020","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.cellsig.2025.112317_bb0410","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.218","article-title":"Metabolic reprogramming in cancer: Mechanisms and therapeutics","volume":"4","author":"Nong","year":"2020","journal-title":"MedComm"},{"issue":"4","key":"10.1016\/j.cellsig.2025.112317_bb0415","first-page":"1206","article-title":"Amino acids of the 6C3HED lymphosarcoma following treatment with asparaginase","volume":"30","author":"Ryan","year":"1970","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2025.112317_bb0420","series-title":"Metabolism of Asparagine and Glycine in Mitochondria and Lymphoma Cells: Metabolic Bases for Resistance to L-Asparaginase","first-page":"203","author":"Moraga Amador","year":"1986"},{"issue":"3924","key":"10.1016\/j.cellsig.2025.112317_bb0425","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1126\/science.167.3924.1512","article-title":"Glycine inhibition of asparaginase","volume":"167","author":"Ryan","year":"1970","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.cellsig.2025.112317_bb0430","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/0006-2952(85)90190-X","article-title":"Comparison of glycine metabolism in mouse lymphoma cells either sensitive or resistant to L-asparaginase","volume":"34","author":"Keefer","year":"1985","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112317_bb0435","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/leu.2010.256","article-title":"A genome-wide approach identifies that the aspartate metabolism pathway contributes to asparaginase sensitivity","volume":"25","author":"Chen","year":"2011","journal-title":"Leukemia"},{"issue":"21","key":"10.1016\/j.cellsig.2025.112317_bb0440","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2019102147","article-title":"SLC1A3 contributes to L-asparaginase resistance in solid tumors","volume":"38","author":"Sun","year":"2019","journal-title":"EMBO J."},{"issue":"5930","key":"10.1016\/j.cellsig.2025.112317_bb0445","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112317_bb0450","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1186\/s12885-020-07020-y","article-title":"Metabolic profile of leukemia cells influences treatment efficacy of L-asparaginase","volume":"20","author":"Hlozkova","year":"2020","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112317_bb0455","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1038\/s41598-022-08049-8","article-title":"PTEN\/PI3K\/Akt pathway alters sensitivity of T-cell acute lymphoblastic leukemia to L-asparaginase","volume":"12","author":"Hlozkova","year":"2022","journal-title":"Sci. Rep."},{"issue":"23","key":"10.1016\/j.cellsig.2025.112317_bb0460","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1182\/blood.V126.23.1285.1285","article-title":"L-asparaginase more effectively targets leukemic cells with low glycolytic activity","volume":"126","author":"Marketa","year":"2015","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.cellsig.2025.112317_bb0465","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1016\/j.celrep.2016.02.004","article-title":"Fatty acid oxidation-driven src links mitochondrial energy reprogramming and oncogenic properties in triple-negative breast cancer","volume":"14","author":"Park","year":"2016","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112317_bb0470","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13045-023-01498-2","article-title":"Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics","volume":"16","author":"Jin","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.cellsig.2025.112317_bb0475","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.canlet.2018.08.006","article-title":"Fatty acid oxidation: an emerging facet of metabolic transformation in cancer","volume":"435","author":"Ma","year":"2018","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112317_bb0480","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/leu.2015.213","article-title":"Pharmacological inhibition of fatty-acid oxidation synergistically enhances the effect of l-asparaginase in childhood ALL cells","volume":"30","author":"Hermanova","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.cellsig.2025.112317_bb0485","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semcancer.2015.04.002","article-title":"Verginadis, II, C. Koumenis, Cell intrinsic and extrinsic activators of the unfolded protein response in cancer: Mechanisms and targets for therapy","volume":"33","author":"Tameire","year":"2015","journal-title":"Semin. Cancer Biol."},{"issue":"3","key":"10.1016\/j.cellsig.2025.112317_bb0490","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3945\/an.112.001891","article-title":"The transcription factor network associated with the amino acid response in mammalian cells","volume":"3","author":"Kilberg","year":"2012","journal-title":"Adv. Nutr."},{"issue":"9","key":"10.1016\/j.cellsig.2025.112317_bb0495","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.tem.2009.05.008","article-title":"ATF4-dependent transcription mediates signaling of amino acid limitation","volume":"20","author":"Kilberg","year":"2009","journal-title":"Trends Endocrinol. Metab."},{"issue":"19","key":"10.1016\/j.cellsig.2025.112317_bb0500","doi-asserted-by":"crossref","first-page":"6681","DOI":"10.1128\/MCB.22.19.6681-6688.2002","article-title":"The GCN2 eIF2alpha kinase is required for adaptation to amino acid deprivation in mice","volume":"22","author":"Zhang","year":"2002","journal-title":"Mol. Cell. Biol."},{"issue":"2","key":"10.1016\/j.cellsig.2025.112317_bb0505","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/genetics\/154.2.787","article-title":"A mammalian homologue of GCN2 protein kinase important for translational control by phosphorylation of eukaryotic initiation factor-2alpha","volume":"154","author":"Sood","year":"2000","journal-title":"Genetics"},{"issue":"8","key":"10.1016\/j.cellsig.2025.112317_bb0510","doi-asserted-by":"crossref","first-page":"4497","DOI":"10.1128\/MCB.15.8.4497","article-title":"The histidyl-tRNA synthetase-related sequence in the eIF-2 alpha protein kinase GCN2 interacts with tRNA and is required for activation in response to starvation for different amino acids","volume":"15","author":"Wek","year":"1995","journal-title":"Mol. Cell. Biol."},{"issue":"33","key":"10.1016\/j.cellsig.2025.112317_bb0515","doi-asserted-by":"crossref","first-page":"E7776","DOI":"10.1073\/pnas.1805523115","article-title":"Inhibition of GCN2 sensitizes ASNS-low cancer cells to asparaginase by disrupting the amino acid response","volume":"115","author":"Nakamura","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"27","key":"10.1016\/j.cellsig.2025.112317_bb0520","doi-asserted-by":"crossref","first-page":"24120","DOI":"10.1074\/jbc.M201959200","article-title":"ATF4 is a mediator of the nutrient-sensing response pathway that activates the human asparagine synthetase gene","volume":"277","author":"Siu","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.cellsig.2025.112317_bb0525","doi-asserted-by":"crossref","first-page":"E789","DOI":"10.1152\/ajpendo.00015.2013","article-title":"Asparagine synthetase: regulation by cell stress and involvement in tumor biology","volume":"304","author":"Balasubramanian","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.cellsig.2025.112317_bb0530","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1182\/bloodadvances.2022006965","article-title":"Amino acid stress response genes promote L-asparaginase resistance in pediatric acute lymphoblastic leukemia","volume":"6","author":"Ferguson","year":"2022","journal-title":"Blood Adv."},{"issue":"23","key":"10.1016\/j.cellsig.2025.112317_bb0535","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1182\/blood.2021011787","article-title":"BTK inhibition sensitizes acute lymphoblastic leukemia to asparaginase by suppressing the amino acid response pathway","volume":"138","author":"Butler","year":"2021","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112317_bb0540","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ccell.2017.12.003","article-title":"Oncogenic KRAS regulates amino acid homeostasis and asparagine biosynthesis via ATF4 and alters sensitivity to L-Asparaginase","volume":"33","author":"Gwinn","year":"2018","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.cellsig.2025.112317_bb0545","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.neo.2016.09.004","article-title":"Metabolic alterations caused by KRAS mutations in colorectal cancer contribute to cell adaptation to glutamine depletion by upregulation of asparagine synthetase","volume":"18","author":"Toda","year":"2016","journal-title":"Neoplasia"},{"issue":"12","key":"10.1016\/j.cellsig.2025.112317_bb0550","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1038\/s41556-019-0415-1","article-title":"Translational reprogramming marks adaptation to asparagine restriction in cancer","volume":"21","author":"Pathria","year":"2019","journal-title":"Nat. Cell Biol."},{"issue":"3","key":"10.1016\/j.cellsig.2025.112317_bb0555","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202051436","article-title":"MAPK signaling regulates c-MYC for melanoma cell adaptation to asparagine restriction","volume":"22","author":"Pathria","year":"2021","journal-title":"EMBO Rep."},{"issue":"7092","key":"10.1016\/j.cellsig.2025.112317_bb0560","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nature04869","article-title":"Ras, PI(3)K and mTOR signalling controls tumour cell growth","volume":"441","author":"Shaw","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.cellsig.2025.112317_bb0565","article-title":"PI3K\/Akt\/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway?","volume":"12","author":"Peng","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cellsig.2025.112317_bb0570","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.semcancer.2021.06.019","article-title":"Attacking the PI3K\/Akt\/mTOR signaling pathway for targeted therapeutic treatment in human cancer","volume":"85","author":"Yu","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"11","key":"10.1016\/j.cellsig.2025.112317_bb0575","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a036780","article-title":"PTEN in autism and neurodevelopmental disorders","volume":"9","author":"Rademacher","year":"2019","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"7","key":"10.1016\/j.cellsig.2025.112317_bb0580","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.3109\/10428194.2011.649478","article-title":"Curcumin potentiates antitumor activity of L-asparaginase via inhibition of the AKT signaling pathway in acute lymphoblastic leukemia","volume":"53","author":"Wang","year":"2012","journal-title":"Leuk. Lymphoma"},{"issue":"8","key":"10.1016\/j.cellsig.2025.112317_bb0585","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23117","article-title":"l-Asparaginase synergizes with etoposide via the PI3K\/Akt\/mTOR pathway in Epstein-Barr virus-positive Burkitt lymphoma","volume":"36","author":"Sang","year":"2022","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"53","key":"10.1016\/j.cellsig.2025.112317_bb0590","doi-asserted-by":"crossref","first-page":"91052","DOI":"10.18632\/oncotarget.19409","article-title":"Autophagy suppression potentiates the anti-glioblastoma effect of asparaginase in vitro and in vivo","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.cellsig.2025.112317_bb0595","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1016\/j.bbrc.2018.06.167","article-title":"l-asparaginase induces intrinsic mitochondrial-mediated apoptosis in human gastric adenocarcinoma cells and impedes tumor progression","volume":"503","author":"Sindhu","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cellsig.2025.112317_bb0600","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ijbiomac.2019.12.156","article-title":"The effect of Yarrowia lipolytical-asparaginase on apoptosis induction and inhibition of growth in Burkitt's lymphoma Raji and acute lymphoblastic leukemia MOLT-4 cells","volume":"146","author":"Mazloum-Ravasan","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.cellsig.2025.112317_bb0605","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1124164","article-title":"Requirement for ER-mitochondria Ca(2+) transfer, ROS production and mPTP formation in L-asparaginase-induced apoptosis of acute lymphoblastic leukemia cells","volume":"11","author":"Lee","year":"2023","journal-title":"Front Cell Dev. Biol."},{"issue":"13","key":"10.1016\/j.cellsig.2025.112317_bb0610","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1038\/s41388-020-1188-5","article-title":"mPTP opening caused by Cdk5 loss is due to increased mitochondrial Ca(2+) uptake","volume":"39","author":"NavaneethaKrishnan","year":"2020","journal-title":"Oncogene"},{"issue":"20","key":"10.1016\/j.cellsig.2025.112317_bb0615","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1182\/blood-2018-12-890236","article-title":"HAP1 loss confers l-asparaginase resistance in ALL by downregulating the calpain-1-Bid-caspase-3\/12 pathway","volume":"133","author":"Lee","year":"2019","journal-title":"Blood"},{"issue":"42","key":"10.1016\/j.cellsig.2025.112317_bb0620","doi-asserted-by":"crossref","first-page":"5910","DOI":"10.1038\/onc.2017.211","article-title":"Genome-wide loss-of-function genetic screening identifies opioid receptor \u03bc1 as a key regulator of L-asparaginase resistance in pediatric acute lymphoblastic leukemia","volume":"36","author":"Kang","year":"2017","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.cellsig.2025.112317_bb0625","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1182\/blood-2007-03-080325","article-title":"Activity of vincristine, L-ASP, and dexamethasone against acute lymphoblastic leukemia is enhanced by the BH3-mimetic ABT-737 in vitro and in vivo","volume":"110","author":"Kang","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.cellsig.2025.112317_bb0630","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1146\/annurev-biochem-061516-044908","article-title":"Proteasomal and autophagic degradation systems","volume":"86","author":"Dikic","year":"2017","journal-title":"Annu. Rev. Biochem."},{"issue":"5756","key":"10.1016\/j.cellsig.2025.112317_bb0635","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1126\/science.1121925","article-title":"Protein synthesis upon acute nutrient restriction relies on proteasome function","volume":"310","author":"Vabulas","year":"2005","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.cellsig.2025.112317_bb0640","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.molcel.2012.08.003","article-title":"Failure of amino acid homeostasis causes cell death following proteasome inhibition","volume":"48","author":"Suraweera","year":"2012","journal-title":"Mol. Cell"},{"issue":"4","key":"10.1016\/j.cellsig.2025.112317_bb0645","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.molcel.2014.04.014","article-title":"Mitotic wnt signaling promotes protein stabilization and regulates cell size","volume":"54","author":"Acebron","year":"2014","journal-title":"Mol. Cell"},{"issue":"4","key":"10.1016\/j.cellsig.2025.112317_bb0650","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.ccell.2019.03.004","article-title":"Synthetic lethality of Wnt pathway activation and asparaginase in drug-resistant acute leukemias","volume":"35","author":"Hinze","year":"2019","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.cellsig.2025.112317_bb0655","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1158\/2159-8290.CD-19-1472","article-title":"Exploiting the therapeutic interaction of WNT pathway activation and asparaginase for colorectal cancer therapy","volume":"10","author":"Hinze","year":"2020","journal-title":"Cancer Discov."},{"issue":"15","key":"10.1016\/j.cellsig.2025.112317_bb0660","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1016\/j.molcel.2022.05.025","article-title":"Supramolecular assembly of GSK3\u03b1 as a cellular response to amino acid starvation","volume":"82","author":"Hinze","year":"2022","journal-title":"Mol. Cell"},{"issue":"12","key":"10.1016\/j.cellsig.2025.112317_bb0665","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/ng.2803","article-title":"Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse","volume":"45","author":"Perez-Andreu","year":"2013","journal-title":"Nat. Genet."},{"issue":"26","key":"10.1016\/j.cellsig.2025.112317_bb0670","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1182\/blood-2014-12-580001","article-title":"Inherited genetic variation in childhood acute lymphoblastic leukemia","volume":"125","author":"Moriyama","year":"2015","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.cellsig.2025.112317_bb0675","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/jnci\/djaa138","article-title":"Association of GATA3 polymorphisms with minimal residual disease and relapse risk in childhood acute lymphoblastic leukemia","volume":"113","author":"Zhang","year":"2021","journal-title":"J. Natl. Cancer Inst."},{"issue":"8","key":"10.1016\/j.cellsig.2025.112317_bb0680","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.507","article-title":"Inherited GATA3 variant associated with positive minimal residual disease in childhood B-cell acute lymphoblastic leukemia via asparaginase resistance","volume":"11","author":"Li","year":"2021","journal-title":"Clin. Transl. Med."},{"issue":"2","key":"10.1016\/j.cellsig.2025.112317_bb0685","doi-asserted-by":"crossref","first-page":"925","DOI":"10.7150\/thno.46655","article-title":"LncRNA BCYRN1-induced autophagy enhances asparaginase resistance in extranodal NK\/T-cell lymphoma","volume":"11","author":"Wang","year":"2021","journal-title":"Theranostics"},{"issue":"30","key":"10.1016\/j.cellsig.2025.112317_bb0690","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1038\/onc.2017.59","article-title":"Autophagy is required for cell survival under L-asparaginase-induced metabolic stress in acute lymphoblastic leukemia cells","volume":"36","author":"Takahashi","year":"2017","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.cellsig.2025.112317_bb0695","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1007\/s00726-014-1775-2","article-title":"Amino acids and autophagy: cross-talk and co-operation to control cellular homeostasis","volume":"47","author":"Carroll","year":"2015","journal-title":"Amino Acids"},{"issue":"16","key":"10.1016\/j.cellsig.2025.112317_bb0700","doi-asserted-by":"crossref","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","article-title":"The tumor microenvironment","volume":"30","author":"Anderson","year":"2020","journal-title":"Curr. Biol."},{"issue":"7","key":"10.1016\/j.cellsig.2025.112317_bb0705","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.7150\/ijbs.72534","article-title":"Tumor heterogeneity reshapes the tumor microenvironment to influence drug resistance","volume":"18","author":"Zhang","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"9","key":"10.1016\/j.cellsig.2025.112317_bb0710","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1182\/blood.V79.9.2370.2370","article-title":"Bone marrow-derived stromal cells prevent apoptotic cell death in B-lineage acute lymphoblastic leukemia","volume":"79","author":"Manabe","year":"1992","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112317_bb0715","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1365-2141.1996.00305.x","article-title":"Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro","volume":"92","author":"Panayiotidis","year":"1996","journal-title":"Br. J. Haematol."},{"issue":"5","key":"10.1016\/j.cellsig.2025.112317_bb0720","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1182\/blood.V96.5.1926","article-title":"Stromal cells regulate survival of B-lineage leukemic cells during chemotherapy","volume":"96","author":"Mudry","year":"2000","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.cellsig.2025.112317_bb0725","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.cmet.2020.09.001","article-title":"Bone marrow mesenchymal stem cells support acute myeloid leukemia bioenergetics and enhance antioxidant defense and escape from chemotherapy","volume":"32","author":"Forte","year":"2020","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.cellsig.2025.112317_bb0730","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1172\/JCI30235","article-title":"Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase","volume":"117","author":"Iwamoto","year":"2007","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.cellsig.2025.112317_bb0735","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/leu.2011.289","article-title":"IGFBP7 participates in the reciprocal interaction between acute lymphoblastic leukemia and BM stromal cells and in leukemia resistance to asparaginase","volume":"26","author":"Laranjeira","year":"2012","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.cellsig.2025.112317_bb0740","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/bjh.15920","article-title":"Acute myeloid leukaemia niche regulates response to L-asparaginase","volume":"186","author":"Michelozzi","year":"2019","journal-title":"Br. J. Haematol."},{"issue":"23","key":"10.1016\/j.cellsig.2025.112317_bb0745","doi-asserted-by":"crossref","first-page":"5164","DOI":"10.1182\/bloodadvances.2020004041","article-title":"ALL blasts drive primary mesenchymal stromal cells to increase asparagine availability during asparaginase treatment","volume":"5","author":"Chiu","year":"2021","journal-title":"Blood Adv."},{"issue":"10","key":"10.1016\/j.cellsig.2025.112317_bb0750","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1182\/bloodadvances.2021006431","article-title":"Restored biosynthetic pathways induced by MSCs serve as rescue mechanism in leukemia cells after L-asparaginase therapy","volume":"7","author":"Alquezar-Artieda","year":"2023","journal-title":"Blood Adv."},{"issue":"8","key":"10.1016\/j.cellsig.2025.112317_bb0755","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1172\/JCI127201","article-title":"Adipocyte and lipid metabolism in cancer drug resistance","volume":"129","author":"Cao","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.cellsig.2025.112317_bb0760","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1097\/RLU.0000000000003340","article-title":"Altered FDG biodistribution in subcutaneous white fat on PET\/CT following l-asparaginase chemotherapy","volume":"46","author":"Young","year":"2021","journal-title":"Clin. Nucl. Med."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112317_bb0765","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.stem.2016.06.001","article-title":"Leukemic stem cells evade chemotherapy by metabolic adaptation to an adipose tissue niche","volume":"19","author":"Ye","year":"2016","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112317_bb0770","doi-asserted-by":"crossref","first-page":"5507","DOI":"10.1038\/s41467-021-25540-4","article-title":"Adipocytes disrupt the translational programme of acute lymphoblastic leukaemia to favour tumour survival and persistence","volume":"12","author":"Heydt","year":"2021","journal-title":"Nat. Commun."},{"issue":"26","key":"10.1016\/j.cellsig.2025.112317_bb0775","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1182\/blood-2014-08-595389","article-title":"Obesity is associated with residual leukemia following induction therapy for childhood B-precursor acute lymphoblastic leukemia","volume":"124","author":"Orgel","year":"2014","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.cellsig.2025.112317_bb0780","doi-asserted-by":"crossref","first-page":"7867","DOI":"10.1158\/0008-5472.CAN-09-0800","article-title":"Adipocytes impair leukemia treatment in mice","volume":"69","author":"Behan","year":"2009","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.cellsig.2025.112317_bb0785","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.leukres.2012.12.013","article-title":"Adipose tissue attracts and protects acute lymphoblastic leukemia cells from chemotherapy","volume":"37","author":"Pramanik","year":"2013","journal-title":"Leuk. Res."},{"issue":"10","key":"10.1016\/j.cellsig.2025.112317_bb0790","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1158\/0008-5472.CAN-12-4402","article-title":"Adipocytes cause leukemia cell resistance to L-asparaginase via release of glutamine","volume":"73","author":"Ehsanipour","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2025.112317_bb0795","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ctrv.2018.02.004","article-title":"Targeting the microenvironment in solid tumors","volume":"65","author":"Belli","year":"2018","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.cellsig.2025.112317_bb0800","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1626581","article-title":"Targeting asparagine potentiates anti-PD-L1 immunotherapy in gastric cancer by enhancing CD8(+) T cell anti-tumor response","volume":"16","author":"Ge","year":"2025","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.cellsig.2025.112317_bb0805","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.1016\/j.ymthe.2025.08.019","article-title":"Asparaginase enhances CAR-T cell antitumor immunity by asparagine metabolic reprogramming and central memory induction in ALL","volume":"33","author":"Zhu","year":"2025","journal-title":"Mol. Ther."},{"issue":"2","key":"10.1016\/j.cellsig.2025.112317_bb0810","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3324\/haematol.2018.199448","article-title":"Hypersensitivity reactions to asparaginase in mice are mediated by anti-asparaginase IgE and IgG and the immunoglobulin receptors Fc\u03b5RI and Fc\u03b3RIII","volume":"104","author":"Rathod","year":"2019","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.cellsig.2025.112317_bb0815","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/MPA.0000000000000394","article-title":"Asparagine synthetase expression and phase I study with L-asparaginase encapsulated in red blood cells in patients with pancreatic adenocarcinoma","volume":"44","author":"Bachet","year":"2015","journal-title":"Pancreas"},{"issue":"10","key":"10.1016\/j.cellsig.2025.112317_bb0820","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1038\/sj.leu.2404369","article-title":"Difference between hematological malignancy and solid tumor research articles published in four major medical journals","volume":"20","author":"Chizuka","year":"2006","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.cellsig.2025.112317_bb0825","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.cmet.2015.09.025","article-title":"Oncogenic myc induces expression of glutamine synthetase through promoter demethylation","volume":"22","author":"Bott","year":"2015","journal-title":"Cell Metab."},{"issue":"7","key":"10.1016\/j.cellsig.2025.112317_bb0830","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/s41419-022-05079-y","article-title":"Activated amino acid response pathway generates apatinib resistance by reprograming glutamine metabolism in non-small-cell lung cancer","volume":"13","author":"Zhou","year":"2022","journal-title":"Cell Death Dis."},{"issue":"8","key":"10.1016\/j.cellsig.2025.112317_bb0835","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.7150\/ijbs.89942","article-title":"The PI3K\/Akt pathway and glucose metabolism: a dangerous liaison in cancer","volume":"20","author":"Fontana","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"16","key":"10.1016\/j.cellsig.2025.112317_bb0840","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1158\/0008-5472.CAN-19-3281","article-title":"p38\u03b3 MAPK is essential for aerobic glycolysis and pancreatic tumorigenesis","volume":"80","author":"Wang","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2025.112317_bb0845","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156949","article-title":"Guggulsterone suppresses osteosarcoma progression by inhibiting glycolysis through MAPK signaling pathway","volume":"144","author":"Wang","year":"2025","journal-title":"Phytomedicine"},{"issue":"5","key":"10.1016\/j.cellsig.2025.112317_bb0850","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1091\/mbc.e11-12-1011","article-title":"Inhibition of fatty acid oxidation enhances oxidative protein folding and protects hepatocytes from endoplasmic reticulum stress","volume":"23","author":"Tyra","year":"2012","journal-title":"Mol. Biol. Cell"},{"issue":"22","key":"10.1016\/j.cellsig.2025.112317_bb0855","doi-asserted-by":"crossref","first-page":"6852","DOI":"10.1158\/1078-0432.CCR-19-0253","article-title":"A fatty acid oxidation-dependent metabolic shift regulates the adaptation of BRAF-mutated melanoma to MAPK inhibitors","volume":"25","author":"Aloia","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112317_bb0860","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41420-025-02554-1","article-title":"The role and mechanism of fatty acid oxidation in cancer drug resistance","volume":"11","author":"Lei","year":"2025","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.cellsig.2025.112317_bb0865","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.tibs.2015.01.002","article-title":"UPR, autophagy, and mitochondria crosstalk underlies the ER stress response","volume":"40","author":"Senft","year":"2015","journal-title":"Trends Biochem. Sci."},{"issue":"11","key":"10.1016\/j.cellsig.2025.112317_bb0870","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nri.2016.100","article-title":"Crosstalk between autophagy and inflammatory signalling pathways: balancing defence and homeostasis","volume":"16","author":"Cadwell","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cellsig.2025.112317_bb0875","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.semcdb.2014.08.006","article-title":"mTOR and autophagy: a dynamic relationship governed by nutrients and energy","volume":"36","author":"Dunlop","year":"2014","journal-title":"Semin. Cell Dev. Biol."},{"issue":"8","key":"10.1016\/j.cellsig.2025.112317_bb0880","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/cdd.2017.43","article-title":"Caspase involvement in autophagy","volume":"24","author":"Tsapras","year":"2017","journal-title":"Cell Death Differ."},{"issue":"7518","key":"10.1016\/j.cellsig.2025.112317_bb0885","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/nature13492","article-title":"Coordinated regulation of protein synthesis and degradation by mTORC1","volume":"513","author":"Zhang","year":"2014","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.cellsig.2025.112317_bb0890","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1074\/jbc.M112.399949","article-title":"Proteasome-dependent activation of mammalian target of rapamycin complex 1 (mTORC1) is essential for autophagy suppression and muscle remodeling following denervation","volume":"288","author":"Quy","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2025.112317_bb0895","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s42003-019-0587-z","article-title":"High-resolution crystal structure of human asparagine synthetase enables analysis of inhibitor binding and selectivity","volume":"2","author":"Zhu","year":"2019","journal-title":"Commun. Biol."},{"issue":"13","key":"10.1016\/j.cellsig.2025.112317_bb0900","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26136394","article-title":"Transcription factors and methods for the pharmacological correction of their activity","volume":"26","author":"Guryanova","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.cellsig.2025.112317_bb0905","first-page":"762","article-title":"Drugging the \u2018undruggable\u2019 KRAS: breakthroughs, challenges, and opportunities in pancreatic cancer","volume":"22","author":"Khan","year":"2025","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.cellsig.2025.112317_bb0910","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40591-015-0040-8","article-title":"Outlook on PI3K\/AKT\/mTOR inhibition in acute leukemia","volume":"3","author":"Fransecky","year":"2015","journal-title":"Mol. Cell Ther."},{"issue":"11","key":"10.1016\/j.cellsig.2025.112317_bb0915","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1002\/jcp.22647","article-title":"Therapeutic resistance resulting from mutations in Raf\/MEK\/ERK and PI3K\/PTEN\/Akt\/mTOR signaling pathways","volume":"226","author":"McCubrey","year":"2011","journal-title":"J. Cell. Physiol."},{"issue":"23","key":"10.1016\/j.cellsig.2025.112317_bb0920","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.2217\/fon-2020-0119","article-title":"Patient-specific multi-omics models and the application in personalized combination therapy","volume":"16","author":"John","year":"2020","journal-title":"Future Oncol."},{"issue":"D1","key":"10.1016\/j.cellsig.2025.112317_bb0925","doi-asserted-by":"crossref","first-page":"D1670","DOI":"10.1093\/nar\/gkae973","article-title":"Generic Diagramming Platform (GDP): a comprehensive database of high-quality biomedical graphics","volume":"53","author":"Jiang","year":"2025","journal-title":"Nucleic Acids Res."},{"issue":"19","key":"10.1016\/j.cellsig.2025.112317_bb0930","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1056\/NEJM196911062811902","article-title":"L-asparaginase: therapeutic and toxic effects in patients with neoplastic disease","volume":"281","author":"Haskell","year":"1969","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.cellsig.2025.112317_bb0935","first-page":"942","article-title":"l-asparaginase in the treatment of neoplastic diseases in children","volume":"31","author":"Jaffe","year":"1971","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.cellsig.2025.112317_bb0940","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/1097-0142(1971)28:4<825::AID-CNCR2820280404>3.0.CO;2-H","article-title":"Therapy of acute leukemia with drug combinations which include asparaginase","volume":"28","author":"Leventhal","year":"1971","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.cellsig.2025.112317_bb0945","first-page":"2020","article-title":"Asparaginase in combination chemotherapy for remission induction of childhood acute lymphocytic leukemia","volume":"33","author":"Pratt","year":"1973","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.cellsig.2025.112317_bb0950","first-page":"535","article-title":"L-asparaginase, vincristine, and prednisone for induction of first remission in acute lymphocytic leukemia","volume":"37","author":"Ortega","year":"1977","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.cellsig.2025.112317_bb0955","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/mpo.2950030410","article-title":"Optimal use of L-asparaginase (NSC-109229) in acute lymphocytic leukemia","volume":"3","author":"Jones","year":"1977","journal-title":"Med. Pediatr. Oncol."},{"issue":"10","key":"10.1016\/j.cellsig.2025.112317_bb0960","first-page":"3893","article-title":"Effective dose of L-asparaginase for induction of remission in previously treated children with acute lymphocytic leukemia: a report from Childrens Cancer Study Group","volume":"39","author":"Ertel","year":"1979","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.cellsig.2025.112317_bb0965","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1056\/NEJM198609113151101","article-title":"Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia","volume":"315","author":"Clavell","year":"1986","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.cellsig.2025.112317_bb0970","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/pbc.22076","article-title":"Clinical course and outcome in children with acute lymphoblastic leukemia and asparaginase-associated pancreatitis","volume":"53","author":"Kearney","year":"2009","journal-title":"Pediatr. Blood Cancer"},{"issue":"13","key":"10.1016\/j.cellsig.2025.112317_bb0975","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1182\/blood-2008-04-149443","article-title":"Pharmacokinetics, pharmacodynamics, efficacy, and safety of a new recombinant asparaginase preparation in children with previously untreated acute lymphoblastic leukemia: a randomized phase 2 clinical trial","volume":"112","author":"Pieters","year":"2008","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.cellsig.2025.112317_bb0980","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1200\/JCO.19.03024","article-title":"Impact of asparaginase discontinuation on outcome in childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group","volume":"38","author":"Gupta","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.cellsig.2025.112317_bb0985","first-page":"5601","article-title":"Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia","volume":"43","author":"Sallan","year":"1983","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.cellsig.2025.112317_bb0990","doi-asserted-by":"crossref","first-page":"4164","DOI":"10.1182\/blood-2006-09-045351","article-title":"Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 9511","volume":"109","author":"Wetzler","year":"2007","journal-title":"Blood"},{"issue":"28","key":"10.1016\/j.cellsig.2025.112317_bb0995","doi-asserted-by":"crossref","first-page":"7161","DOI":"10.1200\/JCO.2005.11.411","article-title":"Long-term results of a randomized trial on extended use of high dose L-asparaginase for standard risk childhood acute lymphoblastic leukemia","volume":"23","author":"Pession","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.cellsig.2025.112317_bb1000","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/pbc.22225","article-title":"Erwinia asparaginase after allergy to E. coli asparaginase in children with acute lymphoblastic leukemia","volume":"54","author":"Vrooman","year":"2010","journal-title":"Pediatr. Blood Cancer"},{"issue":"11","key":"10.1016\/j.cellsig.2025.112317_bb1005","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.3324\/haematol.2013.090563","article-title":"Pediatric Acute Lymphoblastic Leukemia: Efficacy and safety of recombinant E. coli-asparaginase in infants (less than one year of age) with acute lymphoblastic leukemia","volume":"98","author":"van der Sluis","year":"2013","journal-title":"Haematologica"},{"issue":"16","key":"10.1016\/j.cellsig.2025.112317_bb1010","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S1470-2045(15)00363-0","article-title":"Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial","volume":"16","author":"Place","year":"2015","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.cellsig.2025.112317_bb1015","doi-asserted-by":"crossref","first-page":"e419","DOI":"10.1016\/S2352-3026(23)00072-8","volume":"10","author":"Sato","year":"2023","journal-title":"Lancet Haematol."},{"issue":"3","key":"10.1016\/j.cellsig.2025.112317_bb1020","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/s41375-023-02115-4","article-title":"Treatment completion, asparaginase completion, and oncologic outcomes among children, adolescents and young adults with acute lymphoblastic leukemia treated with DFCI Consortium Protocols","volume":"38","author":"Valtis","year":"2024","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.cellsig.2025.112317_bb1025","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1200\/JCO.2012.43.2070","volume":"31","author":"Vrooman","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"23","key":"10.1016\/j.cellsig.2025.112317_bb1030","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V126.23.80.80","article-title":"A multicenter phase II study using a dose intensified pegylated-asparaginase pediatric regimen in adults with untreated acute lymphoblastic leukemia:a DFCI ALL Consortium Trial","volume":"126","author":"DeAngelo","year":"2015","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112317_bb1035","first-page":"75","article-title":"A retrospective comparison of Escherichia coli and polyethylene glycol-conjugated asparaginase for the treatment of adolescents and adults with newly diagnosed acute lymphoblastic leukemia","volume":"15","author":"Liang","year":"2018","journal-title":"Oncol. Lett."},{"issue":"11","key":"10.1016\/j.cellsig.2025.112317_bb1040","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1182\/blood.V112.11.302.302","article-title":"PEG-Asparaginase in Adult Acute Lymphoblastic Leukemia (ALL): efficacy and feasibility analysis with increasing dose levels","volume":"112","author":"Goekbuget","year":"2008","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.cellsig.2025.112317_bb1045","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1182\/blood.V99.8.2734","article-title":"Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer-Children\u2019s Leukemia Group phase 3 trial","volume":"99","author":"Duval","year":"2002","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.cellsig.2025.112317_bb1050","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00432-019-02854-x","article-title":"Reduced vs. standard dose native E. coli-asparaginase therapy in childhood acute lymphoblastic leukemia: long-term results of the randomized trial Moscow-Berlin 2002","volume":"145","author":"Karachunskiy","year":"2019","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.cellsig.2025.112317_bb1055","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1001\/jama.1969.03160360065021","article-title":"Effects of L-asparaginase in acute myelocytic leukemia","volume":"210","author":"Ohnuma","year":"1969","journal-title":"Jama"},{"issue":"3","key":"10.1016\/j.cellsig.2025.112317_bb1060","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1200\/JCO.1993.11.3.538","article-title":"Impact of high-dose cytarabine and asparaginase intensification on childhood acute myeloid leukemia: a report from the Childrens Cancer Group","volume":"11","author":"Wells","year":"1993","journal-title":"J. Clin. Oncol."},{"issue":"5734","key":"10.1016\/j.cellsig.2025.112317_bb1065","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/bmj.4.5734.513","article-title":"Combination chemotherapy using L-asparaginase, daunorubicin, and cytosine arabinoside in adults with acute myelogenous leukaemia","volume":"4","author":"Crowther","year":"1970","journal-title":"Br. Med. J."},{"issue":"7","key":"10.1016\/j.cellsig.2025.112317_bb1070","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/pbc.24470","article-title":"Sequential administration of methotrexate and asparaginase in relapsed or refractory pediatric acute myeloid leukemia","volume":"60","author":"Buaboonnam","year":"2013","journal-title":"Pediatr. Blood Cancer"},{"issue":"3","key":"10.1016\/j.cellsig.2025.112317_bb1075","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1200\/JCO.1988.6.3.499","article-title":"Synergy between high-dose cytarabine and asparaginase in the treatment of adults with refractory and relapsed acute myelogenous leukemia--a Cancer and Leukemia Group B Study","volume":"6","author":"Capizzi","year":"1988","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.cellsig.2025.112317_bb1080","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/sj.leu.2401310","article-title":"Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study","volume":"13","author":"Amylon","year":"1999","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112317_bb1085","doi-asserted-by":"crossref","first-page":"66","DOI":"10.21147\/j.issn.1000-9604.2017.01.08","article-title":"PEG-asparaginase in BFM-90 regimen improves outcomes in adults with newly diagnosed lymphoblastic lymphoma","volume":"29","author":"Zheng","year":"2017","journal-title":"Chin. J. Cancer Res."},{"issue":"9","key":"10.1016\/j.cellsig.2025.112317_bb1090","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1200\/JCO.2001.19.9.2390","volume":"19","author":"Kobrinsky","year":"2001","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.cellsig.2025.112317_bb1095","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.3324\/haematol.2017.165845","article-title":"Prolonged versus standard native E. coli asparaginase therapy in childhood acute lymphoblastic leukemia and non-Hodgkin lymphoma: final results of the EORTC-CLG randomized phase III trial 58951","volume":"102","author":"Mondelaers","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.cellsig.2025.112317_bb1100","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejca.2019.10.020","article-title":"Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of advanced pancreatic cancer: an open-label, randomized Phase IIb trial","volume":"124","author":"Hammel","year":"2020","journal-title":"Eur. J. Cancer"}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656825007326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656825007326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T01:51:09Z","timestamp":1773885069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656825007326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":220,"alternative-id":["S0898656825007326"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.112317","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanistic insights into L-asparaginase resistance in cancers","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.112317","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112317"}}